Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
PRILOCAINE HYDROCHLORIDE (UNII: MJW015BAPH) (PRILOCAINE - UNII:046O35D44R)
Dentsply Pharmaceutical Inc.
PRILOCAINE HYDROCHLORIDE
PRILOCAINE HYDROCHLORIDE 40 mg in 1 mL
SUBMUCOSAL
PRESCRIPTION DRUG
4% Citanest Plain Dental Injection, Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) (40 mg/mL), is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques. Only accepted procedures for these techniques as described in standard textbooks are recommended. Prilocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type and in those rare patients with congenital or idiopathic methemoglobinemia.
4% Citanest Plain Dental Injection, Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) (40 mg/mL), (NDC 66312-630-14) is dispensed in 1.8 mL single-dose cartridges, packed 50 per box.
Abbreviated New Drug Application
CITANEST PLAIN- PRILOCAINE HYDROCHLORIDE INJECTION, SOLUTION DENTSPLY PHARMACEUTICAL INC. ---------- 4% CITANEST PLAIN DENTAL PRILOCAINE HYDROCHLORIDE INJECTION, USP, 4% (72 MG/1.8 ML) (40 MG/ML) (PRILOCAINE HCI INJECTION, USP) For Local Anesthesia in Dentistry Rx only DESCRIPTION 4% Citanest Plain Dental, Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) (40 mg/mL), (prilocaine HCl Injection, USP), is a sterile, non pyrogenic isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. The quantitative composition is shown in Table 1. 4% Citanest Plain Dental, Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) (40 mg/mL), contains prilocaine HCl, which is chemically designated as propanamide, N-(2- methyl-phenyl) -2- (propylamino)-, monohydrochloride and has the following structural formula: C H N O ∙ HCl molecular wt = 256.77 Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. The specific quantitative composition is shown in Table 1. TABLE 1. COMPOSITION PRODUCT IDENTIFICATION FORMULA (MG/ML) PRILOCAINE HCL PH 4% Citanest Plain Dental (Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) 40.0 6.0 to 7.0 13 20 2 Note: Sodium hydroxide or hydrochloric acid may be used to adjust the pH of 4% Citanest Plain Dental Injection (Prilocaine Hydrochloride Injection, USP, 4% (72 mg/1.8 mL) (40 mg/mL)). (40 mg/mL)) CLINICAL PHARMACOLOGY MECHANISM OF ACTION Prilocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action. ONSET AND DURATION OF ACTION When used for infiltration injection in dental patients, the time of onset of anesthesia averages less than 2 minutes with an average duration of soft tissue anesthesia of approximately 2 hours. Based on electrical stimulation studies, 4% Citanest Plain Dental Injection, Prilocaine Hydrochlori Přečtěte si celý dokument